Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for ...

Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with ...

Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...

Work to create a platform for Oxford rail station has been delayed by ongoing efforts to get Botley Road reopened. Network Rail closed Botley Road at the rail bridge as part of a £161m scheme to ...

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...

City council leader Susan Brown has been urged to lobby Network Rail to speed up the delivery of a new platform at Oxford railway station. She posted a video on X, formerly Twitter, informing ...

Work to create a new platform for Oxford rail station has been delayed by ongoing efforts to get Botley Road reopened ...